230 related articles for article (PubMed ID: 16509870)
1. Serum levels of transforming growth factor beta1 are significantly correlated with venous invasion in patients with gastric cancer.
Lin Y; Kikuchi S; Obata Y; Yagyu K;
J Gastroenterol Hepatol; 2006 Feb; 21(2):432-7. PubMed ID: 16509870
[TBL] [Abstract][Full Text] [Related]
2. The significance of serum transforming growth factor beta 1 in detecting of gastric and colon cancers.
Coban S; Yüksel O; Koçkar MC; Köklü S; Basar O; Tutkak H; Ormeci N
Hepatogastroenterology; 2007; 54(77):1472-6. PubMed ID: 17708279
[TBL] [Abstract][Full Text] [Related]
3. An elevated serum level of transforming growth factor-beta 1 (TGF-beta 1) significantly correlated with lymph node metastasis and poor prognosis in patients with gastric carcinoma.
Saito H; Tsujitani S; Oka S; Kondo A; Ikeguchi M; Maeta M; Kaibara N
Anticancer Res; 2000; 20(6B):4489-93. PubMed ID: 11205293
[TBL] [Abstract][Full Text] [Related]
4. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution.
Wu CY; Wu MS; Chiang EP; Chen YJ; Chen CJ; Chi NH; Shih YT; Chen GH; Lin JT
Clin Cancer Res; 2007 Apr; 13(7):2054-60. PubMed ID: 17404086
[TBL] [Abstract][Full Text] [Related]
5. Elevated levels of circulating interleukin-6 and transforming growth factor-beta1 in patients with metastatic prostatic carcinoma.
Adler HL; McCurdy MA; Kattan MW; Timme TL; Scardino PT; Thompson TC
J Urol; 1999 Jan; 161(1):182-7. PubMed ID: 10037394
[TBL] [Abstract][Full Text] [Related]
6. Serum level of transforming growth factor-beta1 (TGF-beta1) and the expression of TGF-beta receptor type II in peripheral blood mononuclear cells in patients with autoimmune hepatitis.
Sakaguchi K; Kitano M; Nishimura M; Senoh T; Ohta T; Terao M; Shinji N; Koide N; Tsuji T
Hepatogastroenterology; 2004; 51(60):1780-3. PubMed ID: 15532825
[TBL] [Abstract][Full Text] [Related]
7. Examination of transforming growth factor beta1 expression in the serum and tumor tissue of gastric cancer.
Suda A; Saito N; Seshimo A; Kameoka S; Kobayashi M
Int Surg; 2009; 94(2):182-8. PubMed ID: 20108624
[TBL] [Abstract][Full Text] [Related]
8. Serum TIMP-1 in gastric cancer patients: a potential prognostic biomarker.
Wang CS; Wu TL; Tsao KC; Sun CF
Ann Clin Lab Sci; 2006; 36(1):23-30. PubMed ID: 16501233
[TBL] [Abstract][Full Text] [Related]
9. Circulating transforming growth factor beta 1 as a predictor of liver metastasis after resection in colorectal cancer.
Tsushima H; Ito N; Tamura S; Matsuda Y; Inada M; Yabuuchi I; Imai Y; Nagashima R; Misawa H; Takeda H; Matsuzawa Y; Kawata S
Clin Cancer Res; 2001 May; 7(5):1258-62. PubMed ID: 11350892
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma TGF-beta1 levels correlate with decreased survival of metastatic breast cancer patients.
Ivanović V; Demajo M; Krtolica K; Krajnović M; Konstantinović M; Baltić V; Prtenjak G; Stojiljković B; Breberina M; Nesković-Konstantinović Z; Nikolić-Vukosavljević D; Dimitrijević B
Clin Chim Acta; 2006 Sep; 371(1-2):191-3. PubMed ID: 16650397
[TBL] [Abstract][Full Text] [Related]
11. Preoperative serum angiopoietin-2 levels correlate with lymph node status in patients with early gastric cancer.
Jo MJ; Lee JH; Nam BH; Kook MC; Ryu KW; Choi IJ; Kim YW; Bae JM
Ann Surg Oncol; 2009 Jul; 16(7):2052-7. PubMed ID: 19408052
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
[TBL] [Abstract][Full Text] [Related]
13. Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.
Vejchapipat P; Theamboonlers A; Poomsawat S; Chittmittrapap S; Poovorawan Y
Eur J Pediatr Surg; 2008 Dec; 18(6):415-8. PubMed ID: 19012231
[TBL] [Abstract][Full Text] [Related]
14. Plasma levels of transforming growth factor-1beta and alpha2-macroglobulin before and after radical prostatectomy: association to clinicopathological parameters.
Sinnreich O; Kratzsch J; Reichenbach A; Gläser C; Huse K; Birkenmeier G
Prostate; 2004 Nov; 61(3):201-8. PubMed ID: 15368477
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of predictive and prognostic significance of serum TGF-beta1 levels in breast cancer according to HER-2 codon 655 polymorphism.
Papadopoulou E; Anagnostopoulos K; Tripsianis G; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
Neoplasma; 2008; 55(3):229-38. PubMed ID: 18348656
[TBL] [Abstract][Full Text] [Related]
16. Serum interleukin-12 levels in patients with gastric cancer.
Murakami S; Okubo K; Tsuji Y; Sakata H; Hamada S; Hirayama R
Surg Today; 2004; 34(12):1014-9. PubMed ID: 15580384
[TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 serum concentration in patients with prostatic cancer and benign prostatic hyperplasia.
Wolff JM; Fandel T; Borchers H; Brehmer B; Jakse G
Br J Urol; 1998 Mar; 81(3):403-5. PubMed ID: 9523660
[TBL] [Abstract][Full Text] [Related]
18. Decreased serum levels of transforming growth factor-beta1 in patients with autism.
Okada K; Hashimoto K; Iwata Y; Nakamura K; Tsujii M; Tsuchiya KJ; Sekine Y; Suda S; Suzuki K; Sugihara G; Matsuzaki H; Sugiyama T; Kawai M; Minabe Y; Takei N; Mori N
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):187-90. PubMed ID: 17030376
[TBL] [Abstract][Full Text] [Related]
19. Serum transforming growth factor-beta1 levels and pancreatic cancer risk: a nested case-control study (Japan).
Lin Y; Kikuchi S; Tamakoshi A; Obata Y; Yagyu K; Inaba Y; Kurosawa M; Kawamura T; Motohashi Y; Ishibashi T;
Cancer Causes Control; 2006 Oct; 17(8):1077-82. PubMed ID: 16933058
[TBL] [Abstract][Full Text] [Related]
20. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
